Certain information has been excluded pursuant to Regulation S-K, Item 601(b)(10)(iv) from this Document because it is both not material and is the type that the registrant treats as private or confidential. STRATEGIC INNOVATION FUND AMENDMENT...Amendment Agreement • May 9th, 2022 • VBI Vaccines Inc/Bc • Pharmaceutical preparations
Contract Type FiledMay 9th, 2022 Company IndustryVariation Biotechnologies Inc., a corporation duly incorporated under the laws of Canada, having its head office located at 310 Hunt Club Road Suite 201, Ottawa, Ontario K1V 1C1.
ContractAmending Agreement • May 9th, 2022 • VBI Vaccines Inc/Bc • Pharmaceutical preparations
Contract Type FiledMay 9th, 2022 Company Industry[***] Certain information has been excluded pursuant to Regulation S-K, Item 601(b)(10)(iv) from this Document because it is both not material and is the type that the registrant treats as private or confidential.
AMENDMENT TO CONSULTING AGREEMENTConsulting Agreement • May 9th, 2022 • VBI Vaccines Inc/Bc • Pharmaceutical preparations • Ontario
Contract Type FiledMay 9th, 2022 Company Industry JurisdictionThis Amendment to Consulting Agreement (the “Amendment”), effective as of December 16th, 2021 (the “Effective Date”), is by and between Variation Biotechnologies Inc., a corporation incorporated pursuant to the laws of Canada (the “Company”) having an address of 310 Hunt Club Road East, Ottawa, Ontario K1V 1C1 and F. Diaz-Mitoma Professional Corporation (Ontario corporation number 002356634) having an address of 210 Barrow Crescent, Kanata, Ontario K2L 2C7 (“Consultant”). The Consultant and Company are sometimes referred to as a “Party” and are collectively referred to as the “Parties”.